Adagio Medical

Focus: Adagio Medical is a medical device biotechnology company focused on continuous lesion ablation systems for cardiac arrhythmias including atrial fibrillation and ventricular tachycardia. The company operates as a pre-revenue stage device innovator based in Laguna Hills, California.

Oncology

Profile data last refreshed 14h ago · AI intelligence enriched 2w ago

Open Jobs

Should You Work at Adagio Medical?

AI assessment

Adagio Medical is a high-risk, high-impact early-stage device play best suited to career seekers comfortable with startup volatility in exchange for formative influence on novel cardiac ablation technologies.

Why Work Here

Early-stage device innovation with multiple active clinical programs (9 trials) across high-prevalence cardiac indications offers exposure to product development from conception to commercialization.

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

9 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Ultra Low Temperature Ablation

Ventricular Tachycardia, Sustained

N/A

Clinical Trials (1)

NCT07650032Cryoablation for Monomorphic Ventricular Tachycardia (VTS)

N/A

Help build intelligence for Adagio Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused pipeline in atrial fibrillation and ventricular tachycardia targets large addressable markets where cryoablation and pulsed field ablation represent emerging therapeutic modalities.

Small team structure (minimal headcount data available) enables direct impact on device design, clinical strategy, and regulatory pathway decisions.

Watch Out For

Pre-revenue stage with unknown funding, cash position, and financial runway creates uncertainty around long-term employment stability and growth capacity.
Minimal hiring activity (4 active roles across Direct Care, Clinical Development, and Other) suggests limited near-term career advancement and team expansion opportunities.
No published clinical data, regulatory milestones, or recent news in available records raises questions about development velocity and commercial readiness timeline.

Generated by Claude from Adagio Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Cryoablation System for Atrial Fibrillation

Atrial Fibrillation

N/A

Pulsed Field Ablation and Pulsed Field Cryoablation

Persistent Atrial Fibrillation

N/A

Clinical Trials (1)

NCT05408754Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation

N/A

cryoablation procedure using the iCLAS Cryoablation System

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT05416086iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

N/A

cryoablation procedure

Sustained VT

N/A

Clinical Trials (1)

NCT05675865Cryoablation for Monomorphic Ventricular Tachycardia

N/A

PolarStart System

Atrial Flutter

N/A

Clinical Trials (1)

NCT02355106Prospective, Multicenter, Investigation of the Adagio Cryoablation System in Subjects With Atrial Flutter

N/A

Cryoablation System

Atrial Fibrillation

N/A

Clinical Trials (3)

NCT02839304Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation

N/A

NCT06384599VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

N/A

NCT04893317Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)

N/A

Adagio AF Cryoablation System

Persistent Atrial Fibrillation

N/A

Clinical Trials (1)

NCT04061603iCLAS™ for Persistent Atrial Fibrillation

N/A

VT Cryoablation System

Ventricular Tachycardia

N/A

Interview Prep Quick Facts

Portfolio: 9 clinical trials

Top TAs: Cardiovascular

Open Roles: 4 active jobs

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Cardiovascular

4 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Adagio Medical

Should You Work at Adagio Medical?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (4)

Sarah's Home Clinical Lead

Direct Care Provider PRN

Direct Care Provider

Professional School Staff

Hiring Trend